Trust in provider and stigma during second-trimester abortion

被引:0
|
作者
Chesnokova, Arina E. [1 ]
Nagendra, Divyah [1 ,4 ]
Dixit, Eshani [1 ,2 ,3 ]
Mcallister, Arden [1 ]
Schachter, Allison [1 ]
Schreiber, Courtney A. [1 ]
Roe, Andrea H. [1 ]
Sonalkar, Sarita [1 ]
机构
[1] Univ Penn, Perelman Sch Med, Dept Obstet & Gynecol, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA
[2] Rutgers Robert Wood Johnson Med Sch, 675 Hoes Lane West, Piscataway, NJ 08854 USA
[3] 3737 Market St,Suite 1230, Philadelphia, PA 19104 USA
[4] Cambridge Hlth Alliance, 1493 Cambridge St, Cambridge, MA 02139 USA
关键词
Abortion; Second trimester; Stigma; Abortion stigma; Trust; Trust in provider; INTERNALIZED STIGMA; HEALTH; SCALE; WOMEN; POPULATION; DEPRESSION; INCENTIVES; PHYSICIANS; VISITS;
D O I
10.1016/j.srhc.2023.100932
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: To determine whether trust in the provider and sociodemographics are associated with individual-level abortion stigma.Methods: We performed a cross sectional and exploratory study design using secondary analysis of a randomized trial that enrolled participants undergoing second trimester abortion. We collected baseline survey data from 70 trial participants to assess stigma (Individual Level of Abortion Stigma scale, ILAS; range 0-4), trust in provider (Trust in Physician scale; range 1-5), anxiety, depression, and sociodemographics. We performed multiple linear regression, for which ILAS score was the outcome of interest. Univariate associations were used to inform the regression model.Results: The mean abortion stigma score was at the low end of the ILAS at 1.21 (range 0.2-2.8, SD 0.66). Age, race, income, BMI, parity, gestational age at time of abortion, and reasons for ending the pregnancy were not significantly associated with the ILAS score. Higher trust in provider scores were (m 4.0, SD 0.49) and inversely related to the ILAS score, even after adjustment for confounders (ll-0.02, CI-0.03 to-0.004, p = 0.013). Screening positive for anxiety or depression was associated with a higher ILAS score ((ll 0.48, CI 0.10, 0.90, p = 0.015); (ll = 0.27 CI-0.097, 0.643)), while cohabitation was associated with lower ILAS score (ll-0.44, CI-0.82 to-0.57, p = 0.025). Conclusions: Trust in an abortion provider, anxiety, depression, and cohabitation are associated with abortion stigma among people seeking second trimester abortion care. Interventions that improve trust in a provider may be an area of focus for addressing abortion stigma. Future research should confirm these findings in larger populations and across diverse locations and demographics and to conduct qualitative research to understand what patients perceive as trust-promoting behaviors and words during abortion encounters.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] NEW THERAPEUTIC POSSIBILITY FOR SECOND-TRIMESTER ABORTION BY INTRAVENOUS SULPROSTONE
    SCHMIDTGOLLWITZER, K
    SCHUSSLER, B
    SCHMIDTGOLLWITZER, M
    ARCHIVES OF GYNECOLOGY, 1979, 228 (1-4): : 402 - 403
  • [42] Comparison of Effectiveness of Sublingual and Vaginal Misoprostol for Second-Trimester Abortion
    Alka A. Mukherjee
    The Journal of Obstetrics and Gynecology of India, 2019, 69 : 246 - 251
  • [43] SECOND-TRIMESTER ABORTION TECHNIQUE STUDY: A PROSPECTIVE COHORT STUDY
    Murthy, A.
    Jacobs, A.
    Westhoff, C.
    CONTRACEPTION, 2009, 80 (02) : 201 - 202
  • [44] Second-trimester abortion care for those with complex medical conditions
    Henkel, Andrea
    Blumenthal, Paul D.
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2022, 34 (06) : 359 - 366
  • [45] Cervical Obstruction Complicating Second-Trimester Abortion Treatment With Misoprostol
    Borgatta, Lynn
    Sayegh, Raja
    Betstadt, Sarah J.
    Stubblefield, Phillip G.
    OBSTETRICS AND GYNECOLOGY, 2009, 113 (02): : 548 - 550
  • [46] Comparison of Effectiveness of Sublingual and Vaginal Misoprostol for Second-Trimester Abortion
    Mukherjee, Alka A.
    JOURNAL OF OBSTETRICS AND GYNECOLOGY OF INDIA, 2019, 69 (03): : 246 - 251
  • [47] Second-trimester abortion caused by Capnocytophaga sputigena:: Case report
    Alanen, A
    Laurikainen, E
    AMERICAN JOURNAL OF PERINATOLOGY, 1999, 16 (04) : 181 - 183
  • [48] Scheduled Hysterectomy for Second-Trimester Abortion in a Patient With Placenta Accreta
    Tocce, Kristina
    Thomas, Virginia Worth
    Teal, Stephanie
    OBSTETRICS AND GYNECOLOGY, 2009, 113 (02): : 568 - 570
  • [49] Mifepristone in second-trimester medical abortion - A randomized controlled trial
    Kapp, Nathalie
    Borgatta, Lynn
    Stubblefield, Phillip
    Vragovic, Olivera
    Moreno, Nilda
    OBSTETRICS AND GYNECOLOGY, 2007, 110 (06): : 1304 - 1310
  • [50] PROSTIN F2 ALPHA FOR SECOND-TRIMESTER ABORTION
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1974, 16 (22): : 89 - 90